|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 | (2006.01) |
| A61P 35/00 | (2018.01) | ||
| A61K 31/55 | (2006.01) | ||
| A61K 31/55 | (2013.01) | ||
| A61K 31/7088 | (2006.01) | ||
| A61K 31/7088 | (2013.01) | ||
| C12N 15/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3615052 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18791516.0 |
| Date of filing the European patent application | 2018-04-25 | |
| (97) | Date of publication of the European application | 2020-03-04 |
| (45) | Date of publication and mention of the grant of the patent | 2023-01-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2018/084417 |
| Date | 2018-04-25 |
| (87) | Number | WO 2018/196782 |
| Date | 2018-11-01 |
| (30) | Number | Date | Country code |
| 201762490774 P | 2017-04-27 | US |
| (72) |
KHOO, Ui Soon , CN
TSOI, Ho Frankie , CN
GONG, Chun Jade , CN
LEE, Kin Wah Terence , CN
|
| (73) |
The University of Hong Kong ,
Pokfulam Road, Hong Kong,
CN
|
| (54) | USE OF HCN INHIBITORS FOR TREATMENT OF CANCER |
| USE OF HCN INHIBITORS FOR TREATMENT OF CANCER |